Publications (32) GONZAGA GARAY ARAMBURU publications

2024

  1. Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective

    Health Economics Review, Vol. 14, Núm. 1

  2. Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry

    Scientific Reports, Vol. 14, Núm. 1

  3. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  4. Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice

    Ophthalmology and Therapy

2023

  1. Análisis coste-utilidad del modelo de unidad de terapia intravítrea (UTI) frente a la administración tradicional de terapia intravítrea

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 11, pp. 619-626

  2. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database

    British Journal of Ophthalmology, Vol. 108, Núm. 2, pp. 253-262

  3. Predictors of stoppage and recurrence of choroidal neovascularization with a Treat- Extend-Stop protocol: 4-year follow-up

    Journal Francais d'Ophtalmologie, Vol. 46, Núm. 10, pp. 1204-1211

2022

  1. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

  2. Factores de riesgo asociados al error refractivo residual tras cirugía de catarata en práctica clínica. Estudio observacional retrospectivo

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 3, pp. 140-148

  3. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

  4. Prediction Error Stabilization and Long-Term Standard Results with a Monofocal Intraocular Lens

    Vision (Switzerland), Vol. 6, Núm. 1

  5. Short-term effectiveness prognostic factors after dexamethasone intravitreal implant in macular edema due to retinal vein occlusion

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1671-1679

2021

  1. Global multi-site, prospective analysis of cataract surgery outcomes following ICHOM standards: the European CAT-Community

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 259, Núm. 7, pp. 1897-1905

  2. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

  3. Safety and efficacy of bilateral simultaneous XEN implant surgery: a pilot study

    International Ophthalmology, Vol. 41, Núm. 3, pp. 859-866

  4. Three-year outcomes of neovascular age-related macular degeneration in eyes that do not develop macular atrophy or subretinal fibrosis

    Translational Vision Science and Technology, Vol. 10, Núm. 13

2020

  1. Optimization of Diabetic Macular Edema Management in the Real World: A Model of Excellence in Retina Units: The EMUREX Initiative

    Ophthalmologica, Vol. 243, Núm. 5, pp. 379-390

  2. Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 6, pp. 300-310

2019

  1. Author Correction: A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies (Scientific Reports, (2018), 8, 1, (15457), 10.1038/s41598-018-33810-3)

    Scientific Reports

2018

  1. A 5-Year Follow-Up Study of the Treatment of Macular Edema Due to Retinal Vein Occlusion Using Dexamethasone Intravitreal Implants

    Journal of Ocular Pharmacology and Therapeutics